
Medical Ikkou Group Co.,Ltd.
3353.TJPXIndustrialsConglomerates
Latest quote
¥2,881
+¥1.00 · +0.03%
3353.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteMedical Ikkou Group Co.,Ltd. is a Japanese enterprise primarily known for managing dispensing pharmacies across the nation. Beyond its extensive pharmacy operations, the company diversified its activities to include the management of various care facilities, such as nursing homes, outpatient nursing centers, and home-visit nursing care services. Its business portfolio also encompasses the wholesale of generic pharmaceuticals and real estate property rentals. Furthermore, the group is active in financial investments, including stakes in both listed and unlisted securities, and participates in merger and acquisition activities. The company currently oversees 93 dispensing pharmacy locations. Established in 1980, Medical Ikkou Group is headquartered in Tsu, Japan.
- Industry
- Conglomerates
- Sector
- Industrials
- Headquarters
- JP
- CEO
- Toshihisa Minamino
- Listed since
- Nov 26, 2004
- Employees
- 1,608
Market position
- Volume
- 2.2K
- 1.22× average
- Average volume
- 1.8K
- Average daily volume
- Market cap
- 10.85B JPY
- Beta
- 0.28
- Market reference 1
Financials
Financial snapshot
Latest / TTMFinancial health
- Altman Z-score
- 2.64
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 54.98B JPY | 48.39B JPY | 39.9B JPY | 33.9B JPY | 33.6B JPY |
| Cost of goods sold | 48.62B JPY | 42.79B JPY | 35.52B JPY | 30.92B JPY | 30.22B JPY |
| Gross profit | 6.36B JPY | 5.61B JPY | 4.38B JPY | 2.97B JPY | 3.37B JPY |
| Selling, general, and administrative | 4.58B JPY | 3.62B JPY | 2.54B JPY | 1.71B JPY | 1.77B JPY |
| Operating expenses | 4.58B JPY | 3.91B JPY | 2.82B JPY | 2.04B JPY | 2.1B JPY |
| Interest income | 15.72M JPY | 7.75M JPY | 1.65M JPY | 1.11M JPY | 1.43M JPY |
| Interest expense | 102.74M JPY | 63.85M JPY | 54.02M JPY | 50.81M JPY | 58.27M JPY |
| Depreciation and amortization | 844.23M JPY | 763.41M JPY | 783.88M JPY | 841.59M JPY | 870.47M JPY |
| Operating income | 1.79B JPY | 1.69B JPY | 1.56B JPY | 935.17M JPY | 1.28B JPY |
| Net income | 1.28B JPY | 1.13B JPY | 1.04B JPY | 759.6M JPY | 852.33M JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 169.33
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
¥100
2025 complete year+150.0% since 2021
2026 partial: ¥60.00
¥40.00
2,021
¥40.00
2,022
¥40.00
2,023
¥50.00
2,024
¥100
2,025
¥60.00
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Aug 28, 2026 | ¥60.00Semi-Annual | Aug 31, 2026 | Aug 28, 2026 |
DividendUpcoming | Feb 25, 2027 | ¥60.00Semi-Annual | Feb 28, 2027 | Feb 25, 2027 |
Dividend | Feb 26, 2026 | ¥60.00Semi-Annual | Feb 28, 2026 | May 1, 2026 |
Dividend | Aug 28, 2025 | ¥60.00Annual | Aug 31, 2025 | Nov 5, 2025 |
Dividend | Feb 27, 2025 | ¥40.00Special | Feb 28, 2025 | May 1, 2025 |
Dividend | Aug 29, 2024 | ¥25.00Semi-Annual | Aug 31, 2024 | Nov 5, 2024 |
Ex-dividend Aug 28, 2026
¥60.00
Semi-Annual
Record Aug 31, 2026 · Payment Aug 28, 2026
Ex-dividend Feb 25, 2027
¥60.00
Semi-Annual
Record Feb 28, 2027 · Payment Feb 25, 2027
Ex-dividend Feb 26, 2026
¥60.00
Semi-Annual
Record Feb 28, 2026 · Payment May 1, 2026
Ex-dividend Aug 28, 2025
¥60.00
Annual
Record Aug 31, 2025 · Payment Nov 5, 2025
Ex-dividend Feb 27, 2025
¥40.00
Special
Record Feb 28, 2025 · Payment May 1, 2025
Ex-dividend Aug 29, 2024
¥25.00
Semi-Annual
Record Aug 31, 2024 · Payment Nov 5, 2024
3353.T peers
Continue in GoAI
Research 3353.Tresearch.disclaimer





